UL Solutions
ULS
67.13
-1.24
-1.81%
UL Solutions
US · ULS
#1222 by market cap
Listed 2024
67.13
-1.24
-1.81%
Live - 5344 symbols - heartbeat 484s ago
· 2026-10-08 04:55
Pre-market
67.16
+0.04%
After-hours
67.13
0.00%
Overnight
67.13
0.00%
- Market cap
- 13.55B
- P/E (TTM)i
- 27.07
- P/Bi
- 8.50
- EPSi
- 1.60
- Div yieldi
- 0.82%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on ULS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 105.42% +0.01pp
- Institutions
- 448 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Private Company62.03%
Mutual Fund36.77%
Hedge Fund3.32%
Public Company1.83%
Sovereign Wealth Fund0.74%
Individual/Insider0.48%
Government Pension Fund0.45%
Family Office/Trust0.20%
Top holders
ULSE Inc
61.30%
Capital Research
5.09%
T. Rowe Price Group, Inc.
4.09%
BlackRock
3.53%
Kayne Anderson Rudnick Investment Management, LLC
2.33%
Vanguard Capital Management, LLC
1.98%
Vanguard Portfolio Management, LLC
1.61%
Janus Henderson Group plc
1.51%
Durable Capital Partners, LP
1.45%
State Street Global Advisors
1.13%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 45 buys · 5 sells
| Name | Role | Stake |
|---|---|---|
| ULSE Inc | -- | 61.30% |
| Jennifer Scanlon | Chief Executive Officer | 0.11% |
| Ryan Robinson | Chief Financial Officer | 0.08% |
| Frank Coyne | Independent Director | 0.06% |
| James Dollive | Independent Director | 0.04% |
| Marla Gottschalk | Independent Director | 0.04% |
| Weifang Zhou | Executive VP and President of Testing, Inspection & Certification | 0.03% |
| Gitte Schjotz | Executive VP and Chief Science & Operations Officer | 0.03% |
| Kevin J. Kennedy | Independent Director | 0.02% |
| John Genovesi | Executive VP and President of Software & Advisory | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-09 | Ryan Robinson | Chief Financial Officer | Other Derivative Acquisition | +39 | -- |
| 2026-09-09 | Michael Thaman | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | James Dollive | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | Kevin J. Kennedy | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | Kevin J. Kennedy | Independent Director | Other Derivative Acquisition | +15 | -- |
| 2026-09-09 | Marla Gottschalk | Independent Director | Other Derivative Acquisition | +19 | -- |
| 2026-09-09 | Sally Susman | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | Sally Susman | Independent Director | Other Derivative Acquisition | +15 | -- |
| 2026-09-09 | Friedrich Hecker | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | Karen Pepping | Chief Accounting Officer | Other Derivative Acquisition | +3 | -- |
| 2026-09-09 | James Shannon | Independent Chairperson | Other Derivative Acquisition | +19 | -- |
| 2026-09-09 | Jennifer Scanlon | Chief Executive Officer | Other Derivative Acquisition | +175 | -- |
| 2026-09-09 | Elisabeth Torstad | Independent Director | Other Derivative Acquisition | +19 | -- |
| 2026-09-09 | Linda Chapin | Executive Vice President | Other Derivative Acquisition | +9 | -- |
| 2026-09-09 | George Williams | Independent Director | Other Derivative Acquisition | +19 | -- |
| 2026-09-09 | Gitte Schjotz | Executive VP and Chief Science & Operations Officer | Other Derivative Acquisition | +25 | -- |
| 2026-09-09 | Vikram Kini | Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-09 | John Genovesi | Executive VP and President of Software & Advisory | Other Derivative Acquisition | +14 | -- |
| 2026-09-09 | Scott D'Angelo | Chief Legal Officer, Executive VP & Corporate Secretary | Other Derivative Acquisition | +20 | -- |
| 2026-09-09 | Charles Hooper | Independent Director | Other Derivative Acquisition | +19 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:55:13 · For reference only, not investment advice and not tailored to your situation.